Stock Chart

SLRX

$0.84 +29.23%
Score: 44.9 HOLD
Pro
Screener
Vol: 18.37x (vs SPY: 23.4x | vs QQQ: 20.4x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Jan 07, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About SLRX - Salarius Pharmaceuticals, Inc. Common Stock

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Key Statistics

Market Cap $4M

This SLRX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track SLRX's price movements with trendlines, gamma walls, and key support/resistance levels.